UroGen Pharma Ltd. - Ordinary Shares (URGN) Social Stream
UROGEN PHARMA LTD (URGN) Price Targets From Analysts
Use the tables below to see what analysts covering UROGEN PHARMA LTD think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-08-05 | 5 | $55 | $30 | $46.5 | $14.61 | 218.28% |
| 2021-11-11 | 4 | $55 | $30 | $46.5 | $14.61 | 218.28% |
| 2021-11-16 | 5 | $51 | $30 | $44 | $14.61 | 201.16% |
| 2022-03-02 | 5 | $51 | $30 | $40 | $14.61 | 173.79% |
| 2022-03-23 | 4 | $51 | $17 | $31 | $14.61 | 112.18% |
| 2022-04-27 | 6 | $51 | $17 | $27 | $14.61 | 84.8% |
| 2022-07-21 | 5 | $51 | $17 | $27 | $14.61 | 84.8% |
| 2022-08-12 | 6 | $51 | $17 | $27 | $14.61 | 84.8% |
| 2022-08-15 | 6 | $51 | $17 | $29.8 | $14.61 | 103.97% |
| 2022-10-26 | 6 | $51 | $20 | $34.4 | $14.61 | 135.46% |
| 2022-11-10 | 6 | $51 | $20 | $33.4 | $14.61 | 128.61% |
| 2022-11-14 | 6 | $47 | $20 | $32.6 | $14.61 | 123.13% |
| 2022-11-23 | 6 | $47 | $20 | $30.8 | $14.61 | 110.81% |
| 2022-12-20 | 6 | $47 | $20 | $30.2 | $14.61 | 106.71% |
| 2023-03-17 | 6 | $47 | $10 | $25.2 | $14.61 | 72.48% |
| 2023-04-10 | 6 | $47 | $10 | $25.5 | $14.61 | 74.54% |
| 2023-05-02 | 5 | $47 | $10 | $25.5 | $14.61 | 74.54% |
| 2023-06-21 | 5 | $47 | $12 | $26 | $14.61 | 77.96% |
| 2023-07-28 | 4 | $47 | $23 | $34.333 | $14.61 | 135% |
| 2023-11-15 | 5 | $54 | $18 | $39.25 | $14.61 | 168.65% |
The Trend in the Analyst Price Target
URGN's average price target has moved down $3.35 over the prior 27 months.
URGN reports an average of 147.13% for its upside potential over the past 39 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-16 | 6 | 47 | 10 | 25.200 | 9.41 | 167.8% |
| 2023-05-02 | 5 | 47 | 10 | 25.500 | 13.06 | 95.25% |
| 2023-06-21 | 4 | 47 | 22 | 30.666 | 11.98 | 155.98% |
| 2023-08-10 | 5 | 54 | 18 | 39.250 | 21.21 | 85.05% |
| 2023-11-15 | 5 | 54 | 18 | 39.250 | 11.58 | 238.95% |
URGN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.4 | 4 | 0 | 1 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
Over the past 35 weeks, URGN's average broker recommendation rating worsened by 0.07.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- URGN has a lower variance in analysts' estimates than -1961.47% of all US stocks.
- URGN has a higher upside potential (average analyst target price relative to current price) than 2043.56% of all US stocks.
- URGN has a higher number of analysts covering the stock than 539.16% of all US stocks.
- In the context of stocks in the small market cap category, UROGEN PHARMA LTD's average analyst price target is greater than 1913.01% of them.
In the Pharmaceutical Products industry, GTHX, AEZS, and MRUS are the three stocks most similar to UROGEN PHARMA LTD regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for URGN? Use POWR Ratings for clearer insight into price direction.